T. Rowe Price Associates’s Lam Research LRCX Stock Holding History

T. Rowe Price Associates’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.83B	Sell	13,239,357 -455,853	-3%	-$102M	0.33%	54
2025 Q4	$2.34B	Buy	13,695,210 +10,666,540	+352%	+$1.66B	0.25%	77
2025 Q3	$406M	Sell	3,028,670 -3,851,229	-56%	-$408M	0.04%	305
2025 Q2	$670M	Buy	6,879,899 +1,140,678	+20%	+$90.5M	0.08%	219
2025 Q1	$417M	Buy	5,739,221 +2,864,863	+100%	+$226M	0.05%	298
2024 Q4	$208M	Sell	2,874,358 -4,217,042	-59%	-$320M	0.02%	423
2024 Q3	$579M	Sell	7,091,400 -17,740,690	-71%	-$1.54B	0.07%	258
2024 Q2	$2.64B	Sell	24,832,090 -4,759,420	-16%	-$456M	0.32%	57
2024 Q1	$2.88B	Buy	29,591,510 +1,429,030	+5%	+$126M	0.35%	57
2023 Q4	$2.21B	Sell	28,162,480 -2,726,860	-9%	-$186M	0.3%	70
2023 Q3	$1.94B	Sell	30,889,340 -6,236,690	-17%	-$410M	0.28%	67
2023 Q2	$2.39B	Sell	37,126,030 -2,054,680	-5%	-$116M	0.33%	53
2023 Q1	$2.08B	Buy	39,180,710 +5,285,860	+16%	+$259M	0.31%	65
2022 Q4	$1.42B	Buy	33,894,850 +28,313,810	+507%	+$1.18B	0.23%	95
2022 Q3	$204M	Sell	5,581,040 -6,667,040	-54%	-$297M	0.03%	358
2022 Q2	$522M	Buy	12,248,080 +9,497,490	+345%	+$452M	0.07%	285
2022 Q1	$148M	Sell	2,750,590 -4,219,630	-61%	-$246M	0.01%	619
2021 Q4	$501M	Buy	6,970,220 +3,357,680	+93%	+$210M	0.05%	351
2021 Q3	$206M	Sell	3,612,540 -3,023,900	-46%	-$184M	0.02%	543
2021 Q2	$432M	Sell	6,636,440 -811,910	-11%	-$51.3M	0.04%	371
2021 Q1	$443M	Sell	7,448,350 -15,169,870	-67%	-$827M	0.04%	360
2020 Q4	$1.07B	Sell	22,618,220 -9,734,930	-30%	-$410M	0.11%	201
2020 Q3	$1.07B	Sell	32,353,150 -8,848,080	-21%	-$305M	0.12%	174
2020 Q2	$1.33B	Buy	41,201,230 +5,114,100	+14%	+$139M	0.17%	128
2020 Q1	$866M	Buy	36,087,130 +16,295,000	+82%	+$469M	0.14%	157
2019 Q4	$579M	Buy	19,792,130 +8,647,480	+78%	+$230M	0.08%	277
2019 Q3	$258M	Sell	11,144,650 -2,590,200	-19%	-$54.4M	0.04%	397
2019 Q2	$258M	Sell	13,734,850 -8,143,890	-37%	-$155M	0.04%	405
2019 Q1	$392M	Sell	21,878,740 -9,955,850	-31%	-$166M	0.06%	309
2018 Q4	$433M	Sell	31,834,590 -52,826,230	-62%	-$757M	0.07%	259
2018 Q3	$1.28B	Buy	84,660,820 +17,306,920	+26%	+$296M	0.19%	126
2018 Q2	$1.16B	Buy	67,353,900 +60,791,320	+926%	+$1.17B	0.18%	127
2018 Q1	$133M	Buy	6,562,580 +1,375,800	+27%	+$27.3M	0.02%	565
2017 Q4	$95.5M	Sell	5,186,780 -2,093,740	-29%	-$41.1M	0.02%	662
2017 Q3	$135M	Buy	7,280,520 +2,623,880	+56%	+$42.6M	0.02%	543
2017 Q2	$65.9M	Sell	4,656,640 -1,053,150	-18%	-$15.4M	0.01%	737
2017 Q1	$73.3M	Sell	5,709,790 -1,190,700	-17%	-$14M	0.01%	683
2016 Q4	$73M	Sell	6,900,490 -283,130	-4%	-$2.88M	0.01%	686
2016 Q3	$68M	Sell	7,183,620 -2,753,330	-28%	-$25.1M	0.01%	698
2016 Q2	$83.5M	Sell	9,936,950 -44,890	-0.4%	-$361K	0.02%	628
2016 Q1	$82.5M	Sell	9,981,840 -2,107,900	-17%	-$15.3M	0.02%	603
2015 Q4	$96M	Sell	12,089,740 -1,505,700	-11%	-$11.3M	0.02%	565
2015 Q3	$88.8M	Sell	13,595,440 -21,907,500	-62%	-$161M	0.02%	597
2015 Q2	$289M	Buy	35,502,940 +5,844,090	+20%	+$45.9M	0.06%	348
2015 Q1	$208M	Buy	29,658,850 +4,892,390	+20%	+$38.7M	0.04%	431
2014 Q4	$196M	Sell	24,766,460 -9,954,270	-29%	-$77.2M	0.04%	432
2014 Q3	$259M	Buy	34,720,730 +3,857,400	+12%	+$27.5M	0.06%	371
2014 Q2	$209M	Buy	30,863,330 +2,414,600	+8%	+$14.4M	0.05%	426
2014 Q1	$156M	Buy	28,448,730 +20,840,130	+274%	+$111M	0.04%	499
2013 Q4	$41.4M	Buy	7,608,600 +5,185,000	+214%	+$27.3M	0.01%	898
2013 Q3	$12.4M	Sell	2,423,600 -128,100	-5%	-$626K	﹤0.01%	1212
2013 Q2	$11.3M	Buy	+2,551,700	New	+$11.5M	﹤0.01%	1214

Other funds holding LRCX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates's LRCX Position: Q1 2026 in Review

T. Rowe Price Associates reduced its Lam Research (LRCX) stake by 3.3% in Q1 2026, selling an estimated $102M and leaving 13,239,357 shares worth $2.83B. The position accounts for 0.33% of the portfolio, ranked #54.

T. Rowe Price Associates first reported a position in LRCX in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.88B in Q1 2024. 2,630 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

T. Rowe Price Associates held 13,239,357 shares of Lam Research worth $2.83B as of Q1 2026.
T. Rowe Price Associates sold 455,853 Lam Research shares in Q1 2026, an estimated $102M.
Lam Research made up 0.33% of T. Rowe Price Associates's portfolio in Q1 2026, its #54 holding.
T. Rowe Price Associates first reported a position in Lam Research in Q2 2013 and has held it in 52 quarters since.
T. Rowe Price Associates's Lam Research position peaked at $2.88B in Q1 2024.
2,630 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.